Nora Ventosa's Lab. Nanomedicine

PERMANENT STAFF

ventosaDra. Nora Ventosa

POST-DOCTORAL RESEARCHERS

Gonzalez Dra. Elisabet González
kober Dra. Mariana Kober
Judit morla foto 02Judit Morlà

 tomsenDra. Judit Tomsen

PhD STUDENTS

Aida Carreño
Marc Martínez
 Rubén García Costas
 Carla Castellar Alvarez
 Marta Alcaina Hernando
 Nerea González Pato
 

TECHNICAL STAFF

Amable Bernabé
David Piña
Arnau Jaumandreau
 



 
 

Nora Ventosa's Projects

  • FEDER Nanbiosis. Convenio entre el CSIC y el Ministerio Economia, Industria y Competividad para el proyecto compra e instalación y puesta a punto de equipamiento y laboratorios de producción. NANBIOSIS-U2,4,6 Y 8. Mineco. Fondos FEDER. POCInt 2014-2020. Convenio OTR03323. 20/09/2017-31/12/2018.
  • FONBIO. Fluorescent organic nanoparticles for bioimaging. ACCIÓ. TECSPR17-1-0035. 16/6/2018-15/6/2020.
  • MAGIC. Magnetically induced drug release from quatsomes. ACCIÓ. TECSPR16-1-0055. 16/09/2017-15/09/2019.
  • MOTHER: Molecule-based materials and supramolecular organizations for therapy, diagnosis and tissue engineering. MAT2016-80826-R, Ministerio de Economia y Competitividad; 01/01/2017 - 31/12/2019; PI: Jaume Veciana and Nora Ventosa.
  • FLOWERS: New fluorescent water-dispersable colloidal nanoparticles for advanced bio-imaging and theranostic applications; 01/03/2017-28/02/2019
  • SMART-4-FABRY: Smart multifunctional GLA-nanoformulation for Fabry disease; H2020-NMBP-2016-2017/H2020-NMBP-2016-two-stage: 720942; 01/01/2017-31/12/2020.
  • NANONAFRES: Preclinics and clinics studies of application to nanovesicles (quatsomes) with EGF in venous ulcer; COMDRI15-1-0023; 15/10/2016-14/10/2019.
  • NANO4DERM: Nanocapsules containing actives for the topic treatment of dermatological diseases; RTC-2016-4567-1; 01/10/2016-31/11/2019.
  • REACTOR: High-pressure reactor for studying processes of preparation of nanostructured materials with compressed fluids; CSIC13-4E-2370.
  • UNDERLIPIDS: Solid lipidic nanoparticles for the subcutaneous administration of antitumoral marine compounds; RTC-2015-3303-1; 24/02/2015-31/12/2018.
  • LIPOCELL: Functionalized nanoliposomes for the development of therapies for intracellular-based diseases. Application to Fabry disease and homozygous familial hypercholesterolemia; 01/12/2014-30/11/2016.
  • TERARMET: Development of therapies for the treatment of rare congenital metabolic diseases; RTC-2014-2207-1; 28/01/2014-31/12/2017.
  • BE-WELL: Bio- and Electro-active molecule-based materials for improving health andsocietal WELLbeing. CTQ2013-40480-R, Ministerio de Economia y Competitividad; 01/01/2014 - 3106/2017; PI: Jaume Veciana and Concepció Rovira.
  • BERENICE: Benznidazol and Triazol REsearch group for Nanomedicine and Innovation on Chagas diseasE; FP7-HEALTH-2012-INNOVATION-1-305937; 01/09/2012-31/08/2017.
  • NANOSTEM: Targeting Combined Therapy to Cancer Stem Cells. IP: Nora Ventosa. Coordinator: Simó Schwartz, Hospital Universitari Vall de Hebrón, Spain. EU European Innovative RTD Projects Proposals in Nanomedicine, EuroNanoMed. Start/End date:01/01/2010-31/12/2012.
  • NANOFABRY: Development of nanomedicines for enzymatic replacement therapy in Fabry Disease. IP: Jaume Veciana / Nora Ventosa. La Marató TV3. Coordinator: Simó Schwartz, Hospital Universitari Vall de Hebrón. Spain. Start/End date: 1/01/2011-31/12/2014.
  • ORALBEADS: Desarrollo de dispersiones sólidas micro/nanoestructuradas para administración oral de compuestos marinos antitumorales.  IP: Nora Ventosa; Coordinator: PHARMA MAR, S.A. Proyecto INNPACTO. IPT-2011-0754-900000: MICINN. Start/End date: 1/01/2011-31/12/2014.
  • DENDRIA. IP: Nora Ventosa. Coordinator: NOSCIRA. Proyecto CENIT CDTI.Start/End date: 1/06/2010-30/06/2013.
  • VITILIGO. IP: Nora Ventosa. Coordinator: 3P BIOPHARMACEUTICALS SL. Proyecto INNPACTO IPT-010000-2010-22 MICINN. Start/End date:1/01/2010-31/12/2012.